Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

In conclusion, CMV reactivation continues to remain a risk factor for poor posttransplant outcomes and does not seem to confer protection against hematologic disease relapse.

http://www.bloodjournal.org/cgi/content/short/127/20/2427?rss=1

Source: Blood - May 18, 2016 Category: Hematology Authors: Teira, P., Battiwalla, M., Ramanathan, M., Barrett, A. J., Ahn, K. W., Chen, M., Green, J. S., Saad, A., Antin, J. H., Savani, B. N., Lazarus, H. M., Seftel, M., Saber, W., Marks, D., Aljurf, M., Norkin, M., Wingard, J. R., Lindemans, C. A., Boeckh, M., R Tags: Immunobiology, Transplantation, Free Research Articles, Clinical Trials and Observations Source Type: research